Indeed, administration of MALAT1 targeting ASOs reduced metastasis in both human lung cancer xenograft models [60] and mouse mammary tumor models [166], while siRNA knockdown of MALAT1 reduced cell motility in vitro models [167]. Here, MALAT1 is linked to lung cancer.